Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TISSUE REGENIX GROUP PLC Board/Management Information 2015

Feb 26, 2015

7973_rns_2015-02-26_852d2b34-7998-4fef-bc90-23e44215f20c.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9636F

Tissue Regenix Group PLC

26 February 2015

Tissue Regenix plc

26 February 2015

Tissue Regenix Group plc

("Tissue Regenix" or the "Company")

Resignation of Dr Alison Fielding as Non-Executive Director

Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "the Group"), the international regenerative medical devices company, announces that Dr Alison Fielding has stepped down as a Non-Executive Director of the Company with immediate effect.

In accordance with the Company's strategy to evolve the composition of the Board, the search for an independent Non-Executive Director is well underway. 

John Samuel, Non-Executive Chairman of Tissue Regenix, commented:

"On behalf of everyone at Tissue Regenix I would like to thank Alison for her valuable contribution to the current Board over the last 2 years and for her involvement with the Company over the past decade.  We wish her all the very best."

Enquiries:

Tissue Regenix Group plc                                                                                                    Tel: 01904 435 176

Antony Odell, Chief Executive Officer

Ian Jefferson, Chief Financial Officer

Tulchan Communications                                                                                                    Tel: 020 7353 4200

Tom Buchanan / Victoria Huxster

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCSEEFSMFISELE